These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: A comparative evaluation of the treatment of typhoid fevers with co-trimoxazole and chloramphenicol in Egypt.
    Author: Hassan A, Hathout S, Safwat Y, Erian M, Wahab MF, Sorensen K, Sippel J, Farid Z.
    Journal: J Trop Med Hyg; 1975 Mar; 78(3):50-3. PubMed ID: 238046.
    Abstract:
    Seventy-two patients with bacteriologically proven enteric fever were treated with either co-trimoxazole (41 cases) or chloramphenicol (31 cases). C0-trimoxazole was found to be superior to chloramphenicol in relieving the toxaemia. The average number of days required for patients to become afebrile was 5-5 days in the co-trimoxazole group and 4-5 days in the chloramphenicol group. The cure rate was 97 per cent in each of the treatment groups. There occurred two relapses in the co-trimoxazole group and four relapses in the chloramphenicol group. No side effects of the co-trimoxazole were detected during the study. Co-trimoxazole can be considered as a good alternative to chloramphenicol in the treatment of the enteric fevers.
    [Abstract] [Full Text] [Related] [New Search]